share_log

If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

如果你在新冠肺炎大流行期間投資1,000美元購買生物納米公司(BioNano)的股票,這是你現在的身價
Benzinga Real-time News ·  2022/09/26 16:16
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.
在2020年新冠肺炎市場崩盤期間買入股票的投資者,在過去兩年總體上經歷了一些大漲。但毫無疑問,自疫情觸底以來,一些大牌股票的表現好於其他股票。
BioNano's Bumpy Road: One company that has been a great investment in the past two years has been biotech stock BioNano Genomics Inc (NASDAQ:BNGO).
生物納米的坎坷之路:在過去的兩年裏,有一家公司一直是一筆巨大的投資,那就是生物科技股。生物納米基因組公司(納斯達克:bngo)。
BioNano's key technology is its Saphyr System, a cytogenetic testing device that detects structural deficiencies within a cell's nucleus. The system then uses genome mapping for disease diagnosis.
BioNano的關鍵技術是其Sassir系統,這是一種細胞遺傳學測試設備,可以檢測細胞核內的結構缺陷。然後,該系統使用基因組圖譜進行疾病診斷。
While the FDA has not approved...
雖然FDA還...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論